Sygnia (JSE: SYG) share price, discussion & sentiment

SYG up 2% to R33.20 today, which is decent given the broader healthcare chop we've seen. Asset manager showing some resilience here, though the dividend yield still feels lean relative to the macro uncertainty.

R45 by end of year ngl

sygnia's been under pressure but the medical devices space in sa isn't going away, rand weakness actually helps export stuff. last close r31.60 feels like folks are spooked more than fundamentals broke. if they can keep margins tight during load shedding chaos, could be interesting longer term. glta

medical devices still fighting headwinds, margins compressed ngl

sygnia bleeding rand weakness tho. medical device play should have some export buffer but if their fx hedging is weak or they're sourcing offshore, margins get squeezed fast. where's the last sens on capex spend or new product pipeline. feels quiet.

Pulled the latest AFS, debt position tightening up a bit

pulled the latest sens filing, balance sheet holding up ngl

syg sitting at r32.40 and the medical device space locally isnt exactly crowded, thats the play here. margins on devices are solid if you get the manufacturing right, africa expansion still early innings. patience looks like a real good idea, catalysts moving forward on the distribution side.

SHARKS COMING BACK FROM BEHIND, SYG WILL TOO!!

SYG sitting at R33.00 and the rand's been getting smacked which usually helps exporters but med device play like this is mostly local exposure so that's not really a tailwind. What matters is whether they can grow earnings off a higher base once load-shedding stops kneecapping hospital capex, that's the real story. Long-term view hasn't changed, just waiting for margins to actually improve when input costs normalise.

SYG sitting at R33.00 and honestly the medical device play still makes sense long term, eish just wish they'd show some proper revenue growth. Africa's got massive healthcare gaps and someone's gotta fill them, might as well be local hey.

SYG sitting at R33.00 and the medical device space locally is still underpenetrated compared to what it should be. Balance sheet is solid enough to weather the rand weakness without getting crushed on imports. Good day to top up if you believe in the healthcare shift post covid, not many pure play med device stocks on the JSE worth a look.

SYG medical devices play solid, just holding R33.00

SYG's up 2.29% today but the rally feels thin given their AUM growth has stalled and fee pressure is real in this market. I reckon the Street's being too generous on valuation here - wouldn't chase it at these levels.

SYG down nearly 5% today. Is this a knee-jerk reaction to market sentiment or are there actual headwinds in the wealth management space we should be watching? Curious what the dividend story looks like at these levels given the pullback.

Sygnia at R3259 is trading flat today, but the real question is whether this wealth management and healthcare admin play can capture meaningful market share as the private healthcare ecosystem consolidates. With structural tailwinds from middle-class growth and the government's c

SYG taking a small knock at R3259 today but the asset management angle doesn't excite me the way agricultural plays do. Compare this to something like Mediclinic which at least has actual healthcare delivery exposure and patient revenue streams. The wealth management space feels

SYG climbing 3% today to R3329 got me thinking: are we pricing in genuine operational leverage from their asset management division, or just riding sentiment off the broader healthcare rally. The dividend yield sits around 2.8% which feels modest compared to my property rental re

SYG up 1.72% today at R3199, but it's still trading at a hefty P/E compared to the broader financials and healthcare space. Like choosing between breeding Merino and Angora sheep, you're paying premium prices here and need to believe the wool quality justifies it.

SYG dropping 1.11% today but I'm looking at their asset management side. With all these ETFs and retirement funds becoming popular in SA, Sygnia's got real growth potential if they can capture more of that market.